Catalent Stock Price - CTLT

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Catalent Inc CTLT NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 49.55 0.00 0.00 0.00 49.55 19:00:00
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Catalent Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 7.25B 146.26M $ 83.60M 0.89 52.90 144.98M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.07M $ - 0.00% - -

more financials information »

Catalent News

Date Time Source News Article
11/05/201913:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)
11/05/201912:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
11/05/201908:40Edgar (US Regulatory)Quarterly Report (10-q)
11/05/201907:34Edgar (US Regulatory)Current Report Filing (8-k)
11/05/201907:30Business WireCatalent, Inc. Reports First Quarter Fiscal 2020 Results
10/31/201907:46Business WireCycle Pharmaceuticals und Catalent nutzen Zydis..
10/31/201907:30Business WireCycle Pharmaceuticals et Catalent s'associent pour..

Latest CTLT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTLT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week49.5550.1848.8949.45570,3020.000.0%
1 Month49.1251.4347.7249.58651,9890.430.88%
3 Months55.8656.1946.4350.39759,371-6.31-11.3%
6 Months43.5058.3843.2851.23733,8556.0513.91%
1 Year38.4058.3829.2344.85793,19611.1529.04%
3 Years25.5358.3822.9440.07760,31224.0294.09%
5 Years24.1458.3818.9234.87753,35425.41105.26%

Catalent Description

Catalent is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191114 11:16:24